Hi all
Aug was that you I was taking to today?
Thanks Kip - no bike just the wife's Merc to see me home.
Aug thanks for doing the lift work here - pretty much done my job for me. I can though add a couple of bits.
In particular I would make reference to Steve's comment about the new platform being enough for a Company in itself, this comment was in response to a question I asked about "how important was this new platform for the Company?" - I asked this question because quite frankly reading the recent announcement about the presention of the data, this importance did not come across as anything really substantial......not to me at least.
Here is the real problem - if the Company was able to get the vibe and detail that was presented today at the AGM out to the market things would indeed be different. Rest assured there is much nashing of teeth from the company over the current share price. I believe they have to be more creative in the way they tackle this yawning gap between what the market believes and what is in fact happening.
I wondered why they did not for example, use a trading halt for the new platform so as to make the market stop and take note, rather, they opted for a lower key style of delivery by addressing the scientific community. Talking to Carol Worth after the AGM shed some light for me as to why they did this and Blue you were right across this. They have formula 3 and formula 4 - whilst 3 brings with it faster absorption it did not improve the onset of action which is the "holy grail". Formula 4 is still not completed but is very close and they (the Company and Carol) are confident this will address the onset of action issue and will be way better than the viagra tablet. Carol did give me an indication of what they were aiming for but in fairness to her I think I will leave that out and wait for the Company to announce this. She also pointed out quite correctly that this is R & D work and nothing is done until it is done. There will have to be another bonking bunny trial which will probably be sometime after March 2017 and then all hell should break loose if they have got it right. I did ask the question "did we go too soon on the live trial rather than waiting for Formula 4 to be finished?" - Carols answer was no, they needed to do the trials sooner in order to be sure they were on the right track.
Also front and centre of my mind was a piece of dialogue from Mike to the meeting, where he reiterated the fact that they were all frustrated at the re-action of the market so far and that he was AS committed to the success of the Company today as he was when he first joined, and pointed out that he had many people who were invested here based on his belief in the Company and was acutely aware of doing his best for them as well as all shareholders.
Happy!Days! you asked about the paediatric study for SUD 001 - no real answer for you here as they are still waiting on the FDA and can not provide a time for when they will hear what needs to be done next.
Joseph tapped the meeting so maybe it may be available to shareholders who could not be there.
Mike and Steve both admitted that missing guidance had hurt the Company and share price and I feel that the consensus is that the blue sky bit has gone and that for there to be any meaningful appreciation of the share price deals will need to be locked away, not breaking news I know, but they do not see any point banging their drums just yet, once they land a second and then third people will begin to take a long second look.
I asked Steve if his presentation in China had solicited any interest from anyone we had not spoken to and his answer was yes, so the data (of which I really don't have a fricken clue) did do its job on at least one group.
Boris and Bucky, it is a shame that you guys can't make an AGM because the insight you gain is invaluable and I believe that would make you both feel a little more comfortable about your investment. The benefit is you can talk to MS, NW, SC and CW afterwards and cross check what they are saying with the others and you can gauge by their demeanour how they feel things are tracking.
No hype today - and Steve was prophetic when he said they needed to concentrate on the future rather than dwell in the past.
Seriously, the numbers that can be thrown around in the Bio space can be pretty impressive and as Aug has mentioned the Sud team really are "David's" in a "Goliath's" world. Ultimately their hard work, not just the boys, but the highly talented ladies under Carol in the lab, our astute team at West Coast and of course some lady luck will see Suda around for a number of years yet.
My prediction for what its worth, the new platform will make Suda too dangerous for the likes of Pfizer to leave us to our own devices and we will be snapped up especially if the Chinese come knocking. Steve did say Pfizer was our preferred partner for Sud 003 - I wonder if that may be just for now.
Happy to field any questions I and Aug may have missed
Cheers
Clyde
Obviously this is not advice and your own research is a must - and I have not had a drop of the nectar of the grape
Expand
(20min delay)